Maternal vaginal microflora during pregnancy and the risk of asthma hospitalization and use of antiasthma medication in early childhood
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Maternal vaginal microflora during pregnancy and the risk of asthma hospitalization and use of antiasthma medication in early childhood. / Benn, Christine Stabell; Thorsen, Poul; Kjær, Birgitte Boysen; Bisgaard, Hans; Andersen, Morten; Rostgaard, Klaus; Björkstén, Bengt; Melbye, Mads.
I: Journal of Allergy and Clinical Immunology, Bind 110, Nr. 1, 2002, s. 72-77.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Maternal vaginal microflora during pregnancy and the risk of asthma hospitalization and use of antiasthma medication in early childhood
AU - Benn, Christine Stabell
AU - Thorsen, Poul
AU - Kjær, Birgitte Boysen
AU - Bisgaard, Hans
AU - Andersen, Morten
AU - Rostgaard, Klaus
AU - Björkstén, Bengt
AU - Melbye, Mads
PY - 2002
Y1 - 2002
N2 - Background: Infants with wheezing and allergic diseases have a microflora that differs from that of healthy infants. The fetus acquires microorganisms during birth when exposed to the maternal vaginal microflora. It is therefore conceivable that the maternal vaginal microflora might influence the establishment of the infant flora and, as a consequence, the development of wheezing and allergic diseases. Objective: We sought to study the associations between the composition of the maternal vaginal microflora and the development of wheezing and asthma in childhood. Methods: We performed a population-based cohort study in Denmark. Vaginal samples for bacterial analysis were obtained during pregnancy. A total of 2927 women (80% of the invited women) completed the study and had 3003 live infants. Infant wheezing was assessed as one or more hospitalizations for asthma between 0 and 3 years of age. Asthma was assessed as use of 3 or more packages of antiasthma medication between 4 and 5 years of age. Results: Maternal vaginal colonization with Ureaplasma urealyticum during pregnancy was associated with infant wheezing (odds ratio [OR], 2.0; 95% CI, 1.2-3.6), but not with asthma, during the fifth year of life. Maternal colonization with staphylococci (OR, 2.2; 95% CI, 1.4-3.4) and use of antibiotics in pregnancy (OR, 1.7; 95% CI, 1.1-2.6) were associated with asthma during the fifth year of life. Conclusion: The composition of the maternal vaginal microflora might be associated with wheezing and asthma in the offspring up to 5 years of age.
AB - Background: Infants with wheezing and allergic diseases have a microflora that differs from that of healthy infants. The fetus acquires microorganisms during birth when exposed to the maternal vaginal microflora. It is therefore conceivable that the maternal vaginal microflora might influence the establishment of the infant flora and, as a consequence, the development of wheezing and allergic diseases. Objective: We sought to study the associations between the composition of the maternal vaginal microflora and the development of wheezing and asthma in childhood. Methods: We performed a population-based cohort study in Denmark. Vaginal samples for bacterial analysis were obtained during pregnancy. A total of 2927 women (80% of the invited women) completed the study and had 3003 live infants. Infant wheezing was assessed as one or more hospitalizations for asthma between 0 and 3 years of age. Asthma was assessed as use of 3 or more packages of antiasthma medication between 4 and 5 years of age. Results: Maternal vaginal colonization with Ureaplasma urealyticum during pregnancy was associated with infant wheezing (odds ratio [OR], 2.0; 95% CI, 1.2-3.6), but not with asthma, during the fifth year of life. Maternal colonization with staphylococci (OR, 2.2; 95% CI, 1.4-3.4) and use of antibiotics in pregnancy (OR, 1.7; 95% CI, 1.1-2.6) were associated with asthma during the fifth year of life. Conclusion: The composition of the maternal vaginal microflora might be associated with wheezing and asthma in the offspring up to 5 years of age.
KW - Antibiotics
KW - Asthma
KW - Childhood
KW - Maternal vaginal microflora
KW - Staphylococci
KW - Ureaplasma urealyticum
KW - Wheezing
UR - http://www.scopus.com/inward/record.url?scp=0036966116&partnerID=8YFLogxK
U2 - 10.1067/mai.2002.125833
DO - 10.1067/mai.2002.125833
M3 - Journal article
C2 - 12110824
AN - SCOPUS:0036966116
VL - 110
SP - 72
EP - 77
JO - Journal of Allergy and Clinical Immunology
JF - Journal of Allergy and Clinical Immunology
SN - 0091-6749
IS - 1
ER -
ID: 259461757